-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

901.P1.41 901. Health Services and Quality Improvement: Non-Malignant Conditions Excluding Hemoglobinopathies: Poster I

Symposia: Health Services and Quality Improvement: Non-Malignant Conditions Excluding Hemoglobinopathies Program: Oral and Poster Abstracts
Type: Poster
Saturday, December 7, 2024: 5:30 PM-7:30 PM
Halls G-H (San Diego Convention Center)

Amaury Monard, MD1,2*, Sanne Tegels3*, Inge Merry3*, Floor Derikx3*, Yvonne Henskens4,5*, Erik AM Beckers, MD, PhD6 and Floor CJI Moenen, MD, PhD7*

1Department of internal medicine, Maastricht University, Maastricht, AL, Belgium
2Carim- school for cardiovascular diseases, Maastricht, Netherlands
3Maastricht University Medical Center + (MUMC+), Maastricht, Netherlands
4CARIM - School for cardiovascular disease, Maastricht, Netherlands
5Maastricht UMC+, Maastricht, NLD
6Maastricht University Medical Center, Maastricht, NLD
7Department of Internal Medicine, Hematology, Maastricht University Medical Center+ and Hemophilia Treatment Center Nijmegen-Eindhoven-Maastricht, Maastricht, Netherlands

Mansour Gergi, MD1, Katherine Wilkinson, MS2*, Andrew Sparks, MS3*, Nicholas S Roetker, PHD MS4*, Hanny Al-Samkari, MD5, Nicholas L Smith6*, Timothy B Plante1*, Mary Cushman1, Allen B Repp, MD MSc1*, Chris E. Holmes, MD, PhD7, Karlyn A. Martin, MD, MS8 and Neil Zakai1

1University of Vermont, Burlington, VT
2University of Vermont Larner College of Medicine, Burlington, VT
3Biomedical Statistics Research Core at the University of Vermont, Burlington, VT
4Chronic Disease Research Group, Hennepin Healthcare Research Institute, Minneapolis, MN
5Division of Hematology, Massachusetts General Hospital, Cambridge, MA
6Department of Epidemiology, University of Washington, Seattle, WA
7Univ. of Vermont, Burlington, VT
8Division of Hematology and Oncology, University of Vermont Larner College of Medicine, Burlington, VT

Zoey I. Harris1, Jan Anderson, PharmD, BCPS, BCACP, RPh2*, Kathryn Taylor, PharmD, BCACP, RPh3*, Evan Draper, PharmD, RPh3*, Ana I. Casanegra, MD4* and Surbhi Shah, MD5

1Arizona, Mayo Clinic Arizona, Phoenix, AZ
2Division of Medicine, Mayo Clinic Minnesota, Rochester, MN
3Division of Medicine, Mayo Clinic Rochester, Rochester, MN
4Gonda Vascular Center, Mayo Clinic, Rochester, MN
5Arizona, Mayo Clinic, Scottsdale, AZ

Lindsay Rivera, MD1, James Davidson1*, Omar Alsharif1*, Albert Thomas Quiery, MD2* and Heidi Worth, MD1

1University of Tennessee Medical Center, Knoxville, TN
2University of Tennessee Medical Center, Knoxville, AK

Christian Kjellander, MD, PhD1,2*, Concetta Crivera, PharmD, MPH3*, Ann Leon, PharmD3*, Qian Cai, MPH, MSc3*, Tina Jacob, PhD4*, Erwei Zeng, PhD4*, Christina V Jones, PhD4*, Amy Leval, PhD5*, Marie Fitzgibbon, MPharm, PhD, MBA6*, Wim Noel, PhD7*, Cathye Shu, MD, PhD8* and Gunnar Larfors, MD, PhD9*

1Department of Internal Medicine, Capio St Göran Hospital, Stockholm, Sweden
2Department of Laboratory Medicine, Karolinska Institute, Stockholm, Sweden
3Janssen Global Services, LLC, a Johnson & Johnson company, Spring House, PA
4Schain Research AB, Stockholm, Sweden
5Janssen-Cilag AB, Solna, Sweden
6Janssen Pharmaceutica NV, Beerse, Belgium
7Medical Affairs Department, Janssen Pharmaceutica NV, Beerse, Belgium
8Janssen Research & Development, LLC, a Johnson & Johnson company, Spring House, PA
9Department of Medical Sciences, Unit of Haematology, Uppsala University, Uppsala, Sweden

Erin Cockrell1, Marion Afonso2*, Kieran Wynne-Cattanach, MSc3*, Sophie Lai, BSc4*, Chris Blazos, BSc3* and Giorgio Castellano3*

1St. Joseph's Children's Hospital, Tampa, FL
2Sanofi, Gentilly, France
3Adelphi Real World, Bollington, United Kingdom
4Adelphi Real World, Macclesfield, United Kingdom

Austin Frisch, MD1*, Minira Aslanova, DO2* and Upama Giri, MD3

1Inova Fairfax, Falls Church, VA
2Inova Fairfax, Alexandria, VA
3Inova Schar Cancer Institute, Vienna, CA

Evelyn M Graham, MT (ASCP)1*, David Mark Graham, MD1*, Molly J Evans, MLS (ASCP) CM1*, Daniel Lucas Smith, MLS (ASCP)1*, Matthew Thomas Brinker1*, Erin M. Pettijohn, MD2 and Thomas Edward Gribbin, MD1*

1The Cancer and Hematology Centers, Grand Rapids, MI
2Cancer and Hematology Centers of Western Michigan, Grand Rapids, MI

Kristi Upadhyaya1,2*, Mehrie H Patel1*, Xiaoying Chen3*, Alok A. Khorana, MD1 and Dana Elizabeth Angelini, MD1

1Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, OH
2Taussig Cancer Institute, Cleveland Clinic Foundation, Troy, MI
3Cleveland Clinic, Quantitative Health Sciences, Lerner Research Institute, Cleveland, OH

Melissa Thomas, MD1*, Spencer Gibson, MD2*, Arianna S Moss, BA3*, Ray Quy, MD2*, Eva Zhao, BS3*, Angelina Wang, BS4*, Ben P Debeusscher, BS4* and Zahra Pakbaz, MD5,6,7,8,9

1Department of Internal Medicine, University California Irvine Health, Orange, CA
2Department of Internal Medicine, University of California Irvine Health, Orange, CA
3University of California Irvine School of Medicine, Irvine, CA
4Division of Hematology/Oncology, University of California Irvine School of Medicine, Orange, CA
5University of California Irvine Medical Center, Orange, CA
6University of California Irvine, School of Medicine, Irvine
7Division of Hematology Oncology, University of California Irvine School of Medicine, Orange, CA
8Chao Family Comprehensive Cancer Center, Orange, CA
9Comprehensive CHAO family Cancer Center, University of California Irvine School of Medicine, Irvine, CA

Srishti Sareen, MD1,2, Jaya Adabala1,2*, Katie Stoops1,2*, Jacob Marler1*, Lindsey Lands, MD1,2* and Alva Weir, MD1,2*

1VA Medical Center, Memphis, TN
2UTHSC, Memphis, TN

Esteban Gomez, MD1, Hanna Salehi, MSc2*, Ella Morton, BSc3* and Marion Afonso4*

1Center for Inherited Blood Disorders, Orange, CA
2Adelphi Real World, Bollington, United Kingdom
3Adelphi Real World, Macclesfield, United Kingdom
4Sanofi, Gentilly, France

Peter Kaplinsky1*, Rohan Singh, MS1*, Thomas F Fusillo, DO, MS1,2*, Avi Leader, MD3, Jeffrey I. Zwicker, MD1 and Simon Mantha, MD, MPH4

1Memorial Sloan Kettering Cancer Center, New York, NY
2Internal Medicine, Icahn School of Medicine at Mount Sinai, Mount Sinai Morningside/West, New York, NY
3Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
4Hematology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY

Kimberley Youkhana, MD, MSCR1, Charles Greenberg, MD2 and Benjamin Djulbegovic, MD PhD2

1Division of Hematology and Oncology, Medical University of South Carolina, Charleston, SC
2Medical University of South Carolina, Charleston, SC

*signifies non-member of ASH